Awards & Accolades

Financial Times Names Dechert Lawyers Among Most Innovative in Europe


Estancia Capital and R&T Deposit Solutions Secure Strategic Investment from GTCR


Dechert Advises Baird Medical on US$370 Million de-SPAC Business Combination

25 Cannon Street

Dechert Moves London Headquarters


French Biotech Company Abivax Closes on €150 Million Structured Debt Financing Transactions

Events & Webinars

Save the Date - Dechert Distressed Investing Forum - November 1

Abstract background of technology and science

DAMITT Q2 2023 Report: When Avoiding Settlements, Does Merger Enforcement Settle for Less?

In our DAMITT Q2 2023 report, we examine the latest key trends in antitrust enforcement, including the emerging divide between the U.S. and the EU on merger settlements and the amount of time parties may now need to successfully get their deals through on both sides of the Atlantic.

Learn More


An Introduction to Dechert